Sigma Planning Corp’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $538K | Sell |
10,088
-2,213
| -18% | -$130K | 0.01% | 796 |
|
|
2025
Q4 | $764K | Buy |
12,301
+454
| +4% | +$28K | 0.02% | 628 |
|
|
2025
Q3 | $712K | Sell |
11,847
-1,236
| -9% | -$75.6K | 0.02% | 667 |
|
|
2025
Q2 | $820K | Sell |
13,083
-3,081
| -19% | -$185K | 0.02% | 566 |
|
|
2025
Q1 | $973K | Sell |
16,164
-2,778
| -15% | -$173K | 0.03% | 503 |
|
|
2024
Q4 | $1.11M | Sell |
18,942
-1,220
| -6% | -$72.5K | 0.03% | 458 |
|
|
2024
Q3 | $1.19M | Sell |
20,162
-1,968
| -9% | -$112K | 0.04% | 444 |
|
|
2024
Q2 | $1.24M | Sell |
22,130
-2,057
| -9% | -$115K | 0.04% | 415 |
|
|
2024
Q1 | $1.42M | Buy |
24,187
+13,176
| +120% | +$744K | 0.04% | 399 |
|
|
2023
Q4 | $594K | Sell |
11,011
-92,405
| -89% | -$4.51M | 0.05% | 407 |
|
|
2023
Q3 | $5.02M | Sell |
103,416
-3,228
| -3% | -$172K | 0.19% | 109 |
|
|
2023
Q2 | $6.02M | Sell |
106,644
-41,554
| -28% | -$2.29M | 0.22% | 91 |
|
|
2023
Q1 | $8M | Sell |
148,198
-4,980
| -3% | -$265K | 0.27% | 77 |
|
|
2022
Q4 | $8.05M | Sell |
153,178
-15,743
| -9% | -$799K | 0.29% | 70 |
|
|
2022
Q3 | $7.97M | Sell |
168,921
-3,014
| -2% | -$156K | 0.3% | 62 |
|
|
2022
Q2 | $8.67M | Sell |
171,935
-20,037
| -10% | -$1.09M | 0.3% | 65 |
|
|
2022
Q1 | $11.7M | Sell |
191,972
-1,453
| -0.8% | -$86.6K | 0.35% | 51 |
|
|
2021
Q4 | $12.7M | Buy |
193,425
+1,179
| +0.6% | +$75.5K | 0.36% | 51 |
|
|
2021
Q3 | $12.1M | Sell |
192,246
-5,802
| -3% | -$370K | 0.36% | 46 |
|
|
2021
Q2 | $11.9M | Sell |
198,048
-12,036
| -6% | -$696K | 0.36% | 49 |
|
|
2021
Q1 | $11.6M | Sell |
210,084
-15,750
| -7% | -$873K | 0.37% | 53 |
|
|
2020
Q4 | $12.3M | Buy |
225,834
+5,058
| +2% | +$264K | 0.42% | 46 |
|
|
2020
Q3 | $11M | Buy |
220,776
+54,906
| +33% | +$2.66M | 0.44% | 41 |
|
|
2020
Q2 | $7.32M | Sell |
165,870
-26,172
| -14% | -$1.12M | 0.32% | 53 |
|
|
2020
Q1 | $7.21M | Sell |
192,042
-38,790
| -17% | -$1.63M | 0.43% | 42 |
|
|
2019
Q4 | $10.2M | Buy |
230,832
+3,582
| +2% | +$151K | 0.43% | 38 |
|
|
2019
Q3 | $9.36M | Buy |
227,250
+42,612
| +23% | +$1.74M | 0.45% | 38 |
|
|
2019
Q2 | $7.41M | Buy |
184,638
+52,224
| +39% | +$1.98M | 0.38% | 48 |
|
|
2019
Q1 | $5.11M | Buy |
132,414
+115,590
| +687% | +$4.2M | 0.29% | 77 |
|
|
2018
Q4 | $560K | Sell |
16,824
-180
| -1% | -$6.23K | 0.04% | 401 |
|
|
2018
Q3 | $645K | Buy |
17,004
+4,728
| +39% | +$168K | 0.04% | 404 |
|
|
2018
Q2 | $411K | Buy |
12,276
+2,418
| +25% | +$78.8K | 0.03% | 517 |
|
|
2018
Q1 | $304K | Buy |
9,858
+762
| +8% | +$23.5K | 0.02% | 603 |
|
|
2017
Q4 | $263K | Sell |
9,096
-6
| -0.1% | -$173 | 0.02% | 661 |
|
|
2017
Q3 | $253K | Sell |
9,102
-282
| -3% | -$7.8K | 0.02% | 673 |
|
|
2017
Q2 | $261K | Buy |
+9,384
| New | +$248K | 0.02% | 612 |
|
|
2016
Q1 | – | Sell |
-32,556
| Closed | -$665K | – | 735 |
|
|
2015
Q4 | $665K | Sell |
32,556
-2,316
| -7% | -$46.3K | 0.09% | 244 |
|
|
2015
Q3 | $647K | Sell |
34,872
-102
| -0.3% | -$2.05K | 0.1% | 233 |
|
|
2015
Q2 | $698K | Sell |
34,974
-5,718
| -14% | -$114K | 0.1% | 250 |
|
|
2015
Q1 | $816K | Sell |
40,692
-2,370
| -6% | -$46.3K | 0.11% | 228 |
|
|
2014
Q4 | $812K | Buy |
+43,062
| New | +$777K | 0.11% | 227 |
|
Other funds holding IHI
Sigma Planning Corp's IHI Position: Q1 2026 in Review
Sigma Planning Corp reduced its iShares US Medical Devices ETF (IHI) stake by 18% in Q1 2026, selling an estimated $130K and leaving 10,088 shares worth $538K. The position accounts for 0.01% of the portfolio, ranked #796.
Sigma Planning Corp first reported a position in IHI in Q4 2014 and has held it in 41 quarters since. The position peaked at $12.7M in Q4 2021. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.
- Sigma Planning Corp held 10,088 shares of iShares US Medical Devices ETF worth $538K as of Q1 2026.
- Sigma Planning Corp sold 2,213 iShares US Medical Devices ETF shares in Q1 2026, an estimated $130K.
- iShares US Medical Devices ETF made up 0.01% of Sigma Planning Corp's portfolio in Q1 2026, its #796 holding.
- Sigma Planning Corp first reported a position in iShares US Medical Devices ETF in Q4 2014 and has held it in 41 quarters since.
- Sigma Planning Corp's iShares US Medical Devices ETF position peaked at $12.7M in Q4 2021.
- 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.
Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.